Cover Image
市場調查報告書

全球流式細胞技術引進趨勢的調查:2015年

2015 Global Survey on Flow Cytometry Adoption Trends

出版商 Frost & Sullivan 商品編碼 330570
出版日期 內容資訊 英文 74 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
全球流式細胞技術引進趨勢的調查:2015年 2015 Global Survey on Flow Cytometry Adoption Trends
出版日期: 2015年05月13日 內容資訊: 英文 74 Pages
簡介

本報告提供全球流式細胞技術引進趨勢相關調查分析,以設備、試劑的利用相關調查結果為基礎、流式細胞儀選擇的推動因素、推薦品牌與其理由、研究所的檢查數量、利用固有產品的理由和方法、臨床用的流式細胞儀、其他技術互補、未滿足需求與課題等相關的系統性資訊。

第1章 調查背景、目的、手法、受訪者的人口統計

第2章 摘要整理

第3章 流式細胞技術的利用

  • 流式細胞儀的利用
  • 利用:研究用/臨床用/產業用
  • 使用彩色總數
  • 使用彩色總數:組織的各類型

第4章 品牌認識

  • 流式細胞技術的綜合性的品牌認識
  • 使用品牌:組織的各類型
  • 使用品牌:應用的各類型
  • 研究用推薦的固有品牌
  • 臨床用推薦的固有品牌

第5章 研究所的預算與未來的引進計劃

  • 研究所綜合性的預算
  • 研究所的預算:組織的各類型
  • 未來的引進:組織的各類型
  • 未來推薦的品牌:組織的各類型

第6章 流式細胞技術的技術互補

  • 流式細胞技術的輔助技術
  • 流式細胞技術的輔助技術:組織的各類型

第7章 檢查數量分析

  • 樣品流入的認識
  • 樣品數量:學術核心研究所、研究機關
  • 樣品數量:政府相關的研究所
  • 樣品數量:民間研究所
  • 樣品數量:醫院檢驗室

第8章 研究用 vs. 臨床用

  • 主要用於研究
  • 其他的研究用
  • 主要用於研究:組織的各類型
  • 其他的研究用:組織的各類型
  • 主要用於臨床
  • 其他臨床用
  • 主要用於臨床:學術
  • 主要用於臨床:民間
  • 主要用於臨床:政府
  • 主要用於臨床:醫院

第9章 主要影響要素

  • 推動因素矩陣定義
  • 選擇流式細胞技術產品時的需求策略性優先順序

第10章 自由回答形式的客戶迴響

  • 未滿足需求:組織的各類型
  • 關注事項
  • 結論
  • 關於詳細內容
  • 免責聲明

第11章 附錄

第12章 關於Frost&Sullivan

目錄
Product Code: NF60-01-00-00-00

An End-user Perspective

The primary goal of this research is to analyze the utilization of flow cytometry instruments and reagents. Key information the survey seeks to collect include factors that drive the selection of flow cytometers, predominantly used applications for flow cytometers, respondents' most preferred brands and why, how laboratories feel about test volumes in 2015, why laboratories are utilizing these specific products and how likely they are to continue using these products, which of the clinical applications use flow cytometer predominantly, other complementary technologies used along with flow cytometry, unmet needs and challenges, cells that are of interest, and laboratory budgets for new equipment/reagent purchases.

Table of Contents

1. RESEARCH BACKGROUND, OBJECTIVES, METHODOLOGY, AND RESPONDENT DEMOGRAPHICS

Research Background, Objectives, Methodology, and Respondent Demographics

  • 1. Research Objectives
  • 2. Research Methodology
  • 3. Research Methodology (continued)
  • 4. Respondent Demographics

2. EXECUTIVE SUMMARY

Executive Summary

  • 1. Top 4 Findings
  • 2. Brand Perception
  • 3. Brand Perception (continued)
  • 4. Complementary Technologies
  • 5. Influencing Factors

3. UTILIZATION OF FLOW CYTOMETRY

Utilization of Flow Cytometry

  • 1. Flow Cytometer Utilization
  • 2. Utilization by Research versus Clinical versus Industrial
  • 3. Overall Number of Colors Used
  • 4. Overall Number of Colors Used by Organization Type

4. BRAND PERCEPTION

Brand Perception

  • 1. Overall Brand Awareness of Flow Cytometry
  • 2. Brands Used by Organization Type
  • 3. Brands Used by Application Type
  • 4. Specific Brands Favored for Research Applications
  • 5. Specific Brands Favored for Clinical Applications

5. LABORATORY BUDGETS AND FUTURE ADOPTION PLANS

Laboratory Budgets and Future Adoption Plans

  • 1. Overall Laboratory Budget
  • 2. Laboratory Budget by Organization Type
  • 3. Future Adoption by Organization Type
  • 4. Future Preferred Brands by Organization Type

6. COMPLEMENTARY TECHNOLOGIES TO FLOW CYTOMETRY

Complementary Technologies to Flow Cytometry

  • 1. Ancillary Technologies to Flow Cytometry
  • 2. Ancillary Technologies to Flow Cytometry by Organization Type

7. TEST VOLUME ANALYSIS

Test Volume Analysis

  • 1. Perception on Sample Inflow
  • 2. Sample Volume-Academic Core Laboratories and Research Institutes
  • 3. Sample Volume-Government Affiliated Centers
  • 4. Sample Volume-Private Labs
  • 5. Sample Volume-Hospital Labs

8. RESEARCH VERSUS CLINICAL USE

Research versus Clinical Use

  • 1. Predominantly Used Research Applications
  • 2. Other Research Applications-Verbatim Responses
  • 3. Predominantly Used Research Applications by Organization Type
  • 4. Other Research Applications by Organization Type-Verbatim Responses
  • 5. Predominantly Used Clinical Applications
  • 6. Other Clinical Applications-Verbatim Responses
  • 7. Predominantly Used Clinical Applications-Academic
  • 8. Predominantly Used Clinical Applications-Private
  • 9. Predominantly Used Clinical Applications-Government
  • 10. Predominantly Used Clinical Applications-Hospitals

9. KEY INFLUENCING FACTORS

Key Influencing Factors

  • 1. Definitions for Drivers Matrix
  • 2. Strategic Prioritization of Needs When Selecting Flow Cytometry Products
  • 3. Strategic Prioritization of Needs When Selecting LIMS Products-Discussion

10. OPEN ENDED-VOICE OF THE CUSTOMER

Open Ended-Voice of the Customer

  • 1. Unmet Needs by Organization Type-Verbatim Responses
  • 2. Unmet Needs by Organization Type-Verbatim Responses (continued)
  • 3. Cells of Interest-Verbatim Responses
  • 4. Cells of Interest-Verbatim Responses (continued)
  • 5. Cells of Interest-Verbatim Responses (continued)
  • 6. Conclusions
  • 7. Want to Learn More?
  • 8. Legal Disclaimer

11. APPENDIX

Appendix

  • 1. Additional Sources of Information

12. THE FROST & SULLIVAN STORY

The Frost & Sullivan Story

  • 1. The Frost & Sullivan Story
  • 2. Value Proposition-Future of Your Company & Career
  • 3. Global Perspective
  • 4. Industry Convergence
  • 5. 360° Research Perspective
  • 6. Implementation Excellence
  • 7. Our Blue Ocean Strategy
Back to Top